WO2001009178A3 - Human chaperone proteins - Google Patents
Human chaperone proteins Download PDFInfo
- Publication number
- WO2001009178A3 WO2001009178A3 PCT/US2000/021313 US0021313W WO0109178A3 WO 2001009178 A3 WO2001009178 A3 WO 2001009178A3 US 0021313 W US0021313 W US 0021313W WO 0109178 A3 WO0109178 A3 WO 0109178A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chaperone proteins
- hcpn
- human chaperone
- provides
- expression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002374743A CA2374743A1 (en) | 1999-08-03 | 2000-08-03 | Human chaperone proteins |
AU65187/00A AU6518700A (en) | 1999-08-03 | 2000-08-03 | Human chaperone proteins |
EP00952500A EP1203015A2 (en) | 1999-08-03 | 2000-08-03 | Human chaperone proteins |
JP2001513984A JP2003529327A (en) | 1999-08-03 | 2000-08-03 | Human chaperone protein |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14690899P | 1999-08-03 | 1999-08-03 | |
US60/146,908 | 1999-08-03 | ||
US16092499P | 1999-10-22 | 1999-10-22 | |
US60/160,924 | 1999-10-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001009178A2 WO2001009178A2 (en) | 2001-02-08 |
WO2001009178A3 true WO2001009178A3 (en) | 2001-09-27 |
Family
ID=26844400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/021313 WO2001009178A2 (en) | 1999-08-03 | 2000-08-03 | Human chaperone proteins |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1203015A2 (en) |
JP (1) | JP2003529327A (en) |
AU (1) | AU6518700A (en) |
CA (1) | CA2374743A1 (en) |
WO (1) | WO2001009178A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646249A (en) * | 1994-02-28 | 1997-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and characterization of a novel chaperone protein |
WO1999047655A2 (en) * | 1998-03-20 | 1999-09-23 | Metagen Gesellschaft Für Genomforschung Mbh | Human nucleic acid fragments with heightened expression in normal breast tissue |
-
2000
- 2000-08-03 JP JP2001513984A patent/JP2003529327A/en active Pending
- 2000-08-03 WO PCT/US2000/021313 patent/WO2001009178A2/en not_active Application Discontinuation
- 2000-08-03 AU AU65187/00A patent/AU6518700A/en not_active Abandoned
- 2000-08-03 CA CA002374743A patent/CA2374743A1/en not_active Abandoned
- 2000-08-03 EP EP00952500A patent/EP1203015A2/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5646249A (en) * | 1994-02-28 | 1997-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and characterization of a novel chaperone protein |
WO1999047655A2 (en) * | 1998-03-20 | 1999-09-23 | Metagen Gesellschaft Für Genomforschung Mbh | Human nucleic acid fragments with heightened expression in normal breast tissue |
Non-Patent Citations (4)
Title |
---|
BIRD C: "Human DNA sequence from clone RP3-336M4 on chromosome 1p36.11-36.2", EMBL SEQUENCE DATABASE, 2 July 1999 (1999-07-02), HEIDELBERG DE, XP002157391 * |
KRIEF ET AL.: "Identification and characterization of cvHsp", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 51, 17 December 1999 (1999-12-17), pages 36592 - 36600, XP002157393 * |
LIEW ET AL.: "B85F Heart Homo sapiens cDNA clone B855, mRNA sequence", EMBL SEQUENCE DATABASE, 20 December 1994 (1994-12-20), HEIDELBERG DE, XP002157392 * |
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 91, 1994, pages 10645 - 10649 * |
Also Published As
Publication number | Publication date |
---|---|
JP2003529327A (en) | 2003-10-07 |
WO2001009178A2 (en) | 2001-02-08 |
AU6518700A (en) | 2001-02-19 |
EP1203015A2 (en) | 2002-05-08 |
CA2374743A1 (en) | 2001-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001012662A3 (en) | Membrane associated proteins | |
WO1999061471A3 (en) | Human transmembrane proteins | |
WO2000000610A3 (en) | Human signal peptide-containing proteins | |
WO2000015793A3 (en) | Human gpcr proteins | |
WO2000021988A3 (en) | Human ankyrin family protein | |
WO2000018922A8 (en) | Human carbohydrate-associated proteins | |
WO2000034477A3 (en) | Neuron-associated proteins | |
WO1999058692A3 (en) | Human apoptosis associated proteins | |
WO2000009709A3 (en) | Proteases and associated proteins | |
WO2000026245A3 (en) | Human membrane transport proteins | |
WO2000012703A3 (en) | Protein transport-associated molecules | |
WO2000017355A3 (en) | Human cytoskeleton associated proteins | |
WO2001007612A3 (en) | Receptors and associated proteins | |
WO2001020004A3 (en) | Protein phosphatase and kinase proteins | |
WO2000052151A3 (en) | Human secretory proteins | |
WO2000078953A3 (en) | Human transport proteins | |
WO2000014251A3 (en) | Human transferase proteins | |
WO1999058558A3 (en) | Cell signaling proteins | |
WO1999061614A3 (en) | Human socs proteins | |
WO2001044448A3 (en) | Human oxidoreductase proteins | |
WO2000031263A3 (en) | Gtpase associated proteins | |
WO2000028045A3 (en) | Human hydrolase proteins | |
WO2000042201A3 (en) | Human peptidases | |
WO2000065054A3 (en) | Human membrane-associated proteins | |
WO2000008155A3 (en) | Human receptor-associated proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2374743 Country of ref document: CA Ref country code: CA Ref document number: 2374743 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10049742 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000952500 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000952500 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000952500 Country of ref document: EP |